ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2147

Primary and Secondary Prevention of Osteoporotic Fracture in the Elderly Patients

Belén Miguel Ibáñez1, Carmen Pablos Hernández2, Marta Ibáñez Martínez1, Carolina Cristina Chacón Vélez3, Laura Blanco Ramis3, Sergio Cimadevila Santiago1, Olga Martínez González3, Ana Isabel Turrión Nieves3, Manuel Cipriano Martín Martínez3, Cristina Hidalgo Calleja1, Carlos Montilla Morales1, Olga Compán Fernández3, Lourdes Lorenzo Rodríguez1, José Vicente Hernández Madrid1, Susana Gómez Castro3, Juan Francisco Blanco Blanco4 and Alfonso González Ramírez2, 1University Healthcare Complex of Salamanca, Rheumatology, Salamanca, Spain, 2University Healthcare Complex of Salamanca, Geriatric, Salamanca, Spain, 3University Healthcare Complex of Salamanca, Rheumatology, Salamanca, Castilla y Leon, Spain, 4University Healthcare Complex of Salamanca Traumatology, Salamanca, Spain

Meeting: ACR Convergence 2024

Keywords: Fracture, osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoporosis is a common disease of the elderly patient. It is often under-diagnosed and is known with the onset of fragility fracture. Furthermore, despite subsequent treatment, fractures sometimes continue to occur.

The aim of the study is to describe the clinical characteristics and the evolution during the first year of a cohort of elderly patients after suffering an osteoporotic hip fracture.

Methods: An observational, descriptive, prospective longitudinal study was conducted by analyzing fractures and previous treatments, hip fracture and evolution at one year of 608 elderly patients hospitalised in 2022 and 2023 for hip fracture from discharge from the process until February 2024. Statistical analysis was performed using SPSS software.

Results: The average age of the patients was 87.28 years, with a range of 62-102 years and a predominance of women (455).

The characteristics of the hip fractures are summarized in Table 1. All were caused by low-impact trauma and all patients had at least one risk factor for falls according to the Downton scale.

Prior to their hip fracture, 155 patients had suffered a previous low-impact fracture. The most frequent was at the level of the lower limb (60). More than one previous fracture was found in 20 cases. However, only 17 had received antiresorptive or osteoforming treatment (table 1).

 After the hip fracture, anti-osteoporotic treatment was prescribed to all patients. The most frequently used being denosumab (481).

227 patients would have completed one year of hip fracture evolution. In 12 cases a new fragility fracture due to falls appeared. These 12 patients presented a total lack of adherence to the prescribed anti-osteoporotic treatment.

Conclusion: -Falls are a high-risk geriatric syndrome for the elderly.

-Osteoporosis continues to be an under-diagnosed disease whose first manifestation in the form of a fracture conditions the prognosis of patients’ lives.

-Adherence to anti-osteoporotic treatment is insufficient. Long-term follow-up is required to monitor adherence to anti-osteoporotic treatment and avoid refractures.

Supporting image 1


Disclosures: B. Miguel Ibáñez: None; C. Pablos Hernández: None; M. Ibáñez Martínez: None; C. Chacón Vélez: None; L. Blanco Ramis: None; S. Cimadevila Santiago: None; O. Martínez González: None; A. Turrión Nieves: None; M. Martín Martínez: None; C. Hidalgo Calleja: None; C. Montilla Morales: None; O. Compán Fernández: None; L. Lorenzo Rodríguez: None; J. Hernández Madrid: None; S. Gómez Castro: None; J. Blanco Blanco: None; A. González Ramírez: None.

To cite this abstract in AMA style:

Miguel Ibáñez B, Pablos Hernández C, Ibáñez Martínez M, Chacón Vélez C, Blanco Ramis L, Cimadevila Santiago S, Martínez González O, Turrión Nieves A, Martín Martínez M, Hidalgo Calleja C, Montilla Morales C, Compán Fernández O, Lorenzo Rodríguez L, Hernández Madrid J, Gómez Castro S, Blanco Blanco J, González Ramírez A. Primary and Secondary Prevention of Osteoporotic Fracture in the Elderly Patients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/primary-and-secondary-prevention-of-osteoporotic-fracture-in-the-elderly-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/primary-and-secondary-prevention-of-osteoporotic-fracture-in-the-elderly-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology